Revenue Dynamics YoY (Last Twelve Months): Arrowhead Pharmaceuticals (ARWR)

Public company logo of Arrowhead Corp (ARWR)

Arrowhead Pharmaceuticals (ARWR) is aggressively competing with industry behemoths for leadership in liver therapy, which is reflected in the volatility of the trailing annual revenue change chart. The current value of the parameter is -45.90. While this trend captures the company's authority in RNA interference, the lack of mass-market commercial products and a reliance on partners fail to create sustainable market momentum.

ARWR - Arrowhead Pharmaceuticals Sales Growth YoY (Last Twelve Months) over the range 02/11/2024 - 11/18/2026

Arrowhead Pharmaceuticals, Inc. (ARWR) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Arrowhead Pharmaceuticals
Mass-produced product of arrowheadpharma.com

Year-over-year sales growth (TTM) measures the revenue scaling rate over the last twelve months, neutralizing seasonal fluctuations and one-time adjustments. For Arrowhead Pharmaceuticals (ARWR), this metric reflects the effectiveness of RNA technology commercialization and the volume of partner payments. By analyzing the annual revenue dynamics via the TTM indicator on the GURU.Markets platform, an investor can discern the actual speed of business expansion. A steady acceleration of this metric confirms the success of clinical trials and the market potential of the drugs.